Tony Butler
Stock Analyst at Rodman & Renshaw
(0.95)
# 3,632
Out of 4,842 analysts
105
Total ratings
31.37%
Success rate
-14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $7.54 | +231.79% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $3.14 | +250.32% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.45 | +1,141.38% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.63 | +470.34% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.37 | +2,080.43% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.54 | +2,848.22% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.27 | +3,561.66% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.25 | +700.00% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $36.33 | +106.44% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $54.88 | -36.22% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.71 | +2,118.11% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.49 | +772.37% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.41 | +494.53% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.15 | +1,210.04% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.40 | +6,150.00% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.22 | +1,134.57% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.17 | +360.83% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.75 | +873.54% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.27 | +4,976.45% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $8.85 | +577.97% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.14 | +5,684.53% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.50 | +1,100.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $8.30 | +4,237.35% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.73 | -46.38% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.44 | +237.84% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.32 | +658.32% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.15 | +597.64% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $7.15 | +1,438.46% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.48 | +16,514.75% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $7.54
Upside: +231.79%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $3.14
Upside: +250.32%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.45
Upside: +1,141.38%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.63
Upside: +470.34%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.37
Upside: +2,080.43%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.54
Upside: +2,848.22%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.27
Upside: +3,561.66%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $36.33
Upside: +106.44%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $54.88
Upside: -36.22%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.71
Upside: +2,118.11%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.49
Upside: +772.37%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $8.41
Upside: +494.53%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.15
Upside: +1,210.04%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.40
Upside: +6,150.00%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.22
Upside: +1,134.57%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $2.17
Upside: +360.83%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $1.75
Upside: +873.54%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.27
Upside: +4,976.45%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $8.85
Upside: +577.97%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.14
Upside: +5,684.53%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.50
Upside: +1,100.00%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $8.30
Upside: +4,237.35%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.73
Upside: -46.38%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $4.44
Upside: +237.84%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.32
Upside: +658.32%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $2.15
Upside: +597.64%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $7.15
Upside: +1,438.46%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.48
Upside: +16,514.75%